Some of the most widely used drugs in the U.S. may be heading for lower prices under Medicare, a move that could save taxpayers billions of dollars and squeeze profits
The U.S. government is preparing to release a list this week of 10 drugs that Medicare will be able to negotiate prices for one of the key elements of President Joe Biden s signature Inflation Reduction Act.
Analysts expect Johnson & Johnson's Xarelto blood thinner and Indianapolis-based Eli Lilly and Co.'s Jardiance for diabetes to be among the medications chosen.
Billion-dollar drugs' makers set to face their first US price negotiations newsobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsobserver.com Daily Mail and Mail on Sunday newspapers.
Billion-dollar drugs' makers set to face their first US price negotiations – Hartford Courant courant.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courant.com Daily Mail and Mail on Sunday newspapers.